Abstract: A method of preventing asthma is presented. A therapeutically effective amount of at least one soy isoflavone is administered to those patients exhibiting a PAI-1 risk genotype of 4G4G or 4G5G. The administration of the at least one soy isoflavone prevents development of asthma in the patients, particularly in pediatric patients which have suffered a viral illness within the first few years of life. Administration of the soy isoflavones to those pediatric patients throughout the viral season is beneficial in preventing the development of asthma.

Abstract: The invention relates to methods for treatment of asthma and chronic obstructive pulmonary disease (COPD) by administration of antagonists to plasminogen activator inhibitor type-1 (PAI-1). Suitable atagonists include antibodies, peptides, proteins, nucleic acids, small organic molecules and polymers.

Abstract: Plasminogen activator inhibitor-1 (PAI-1) antagonists can be used in the treatment of asthma and chronic obstructive pulmonary disease.

Abstract: The present invention relates to a structure of vehicle back mirror which is provided at an external side portion of a vehicle, and which is made such that the back mirror is folded and unfolded by operation of a handling button provided within the vehicle. A forward and reverse rotation motor is provided within an interior of the back mirror. The back mirror includes a fixed member, a moving member, a band spring provided on a top surface of a gear and is extended and contracted by a driving force of the motor, so that the moving member, which is firmly fixed to an end of the band spring, is folded and unfolded within a predetermined angle range.